| A1C variability and the risk of microvascular complications in type 1 diabetes: data from the Diabetes Control and Complications Trial ES Kilpatrick, AS Rigby, SL Atkin Diabetes care 31 (11), 2198-2202, 2008 | 513 | 2008 |
| Insulin Resistance, the Metabolic Syndrome, and Complication Risk in Type 1 Diabetes: “Double diabetes” in the Diabetes Control and Complications Trial ES Kilpatrick, AS Rigby, SL Atkin Diabetes care 30 (3), 707-712, 2007 | 502 | 2007 |
| Beneficial effects of soy phytoestrogen intake in postmenopausal women with type 2 diabetes V Jayagopal, P Albertazzi, ES Kilpatrick, EM Howarth, PE Jennings, ... Diabetes care 25 (10), 1709-1714, 2002 | 482 | 2002 |
| The effect of glucose variability on the risk of microvascular complications in type 1 diabetes ES Kilpatrick, AS Rigby, SL Atkin Diabetes care 29 (7), 1486-1490, 2006 | 461 | 2006 |
| Biological variation of cystatin C: implications for the assessment of glomerular filtration rate BG Keevil, ES Kilpatrick, SP Nichols, PW Maylor Clinical chemistry 44 (7), 1535-1539, 1998 | 417 | 1998 |
| Relating mean blood glucose and glucose variability to the risk of multiple episodes of hypoglycaemia in type 1 diabetes ES Kilpatrick, AS Rigby, K Goode, SL Atkin Diabetologia 50, 2553-2561, 2007 | 277 | 2007 |
| The effect of anaemia and abnormalities of erythrocyte indices on HbA1c analysis: a systematic review E English, I Idris, G Smith, K Dhatariya, ES Kilpatrick, WG John Diabetologia 58, 1409-1421, 2015 | 260 | 2015 |
| Biological variation of glycated hemoglobin: implications for diabetes screening and monitoring ES Kilpatrick, PW Maylor, BG Keevil Diabetes Care 21 (2), 261-264, 1998 | 225 | 1998 |
| High‐cocoa polyphenol‐rich chocolate improves HDL cholesterol in Type 2 diabetes patients DD Mellor, T Sathyapalan, ES Kilpatrick, S Beckett, SL Atkin Diabetic medicine 27 (11), 1318-1321, 2010 | 221 | 2010 |
| The obesity paradox in type 2 diabetes mellitus: relationship of body mass index to prognosis: a cohort study P Costanzo, JGF Cleland, P Pellicori, AL Clark, D Hepburn, ES Kilpatrick, ... Annals of internal medicine 162 (9), 610-618, 2015 | 209 | 2015 |
| Effect of glucose variability on the long-term risk of microvascular complications in type 1 diabetes ES Kilpatrick, AS Rigby, SL Atkin Diabetes care 32 (10), 1901-1903, 2009 | 192 | 2009 |
| Orlistat is as beneficial as metformin in the treatment of polycystic ovarian syndrome V Jayagopal, ES Kilpatrick, S Holding, PE Jennings, SL Atkin The Journal of Clinical Endocrinology & Metabolism 90 (2), 729-733, 2005 | 183 | 2005 |
| The biological variation of testosterone and sex hormone-binding globulin (SHBG) in polycystic ovarian syndrome: implications for SHBG as a surrogate marker of insulin resistance V Jayagopal, ES Kilpatrick, PE Jennings, DA Hepburn, SL Atkin The Journal of Clinical Endocrinology & Metabolism 88 (4), 1528-1533, 2003 | 180 | 2003 |
| The effect of atorvastatin in patients with polycystic ovary syndrome: a randomized double-blind placebo-controlled study T Sathyapalan, ES Kilpatrick, AM Coady, SL Atkin The Journal of Clinical Endocrinology & Metabolism 94 (1), 103-108, 2009 | 176 | 2009 |
| The effect of iron and erythropoietin treatment on the A1C of patients with diabetes and chronic kidney disease JM Ng, M Cooke, S Bhandari, SL Atkin, ES Kilpatrick Diabetes care 33 (11), 2310-2313, 2010 | 168 | 2010 |
| Variability in the Relationship between Mean Plasma Glucose and HbA1c: Implications for the Assessment of Glycemic Control ES Kilpatrick, AS Rigby, SL Atkin Clinical chemistry 53 (5), 897-901, 2007 | 168 | 2007 |
| Is haemoglobin A1c a step forward for diagnosing diabetes? ES Kilpatrick, ZT Bloomgarden, PZ Zimmet Bmj 339, 2009 | 154 | 2009 |
| Establishing pragmatic estimated GFR thresholds to guide metformin prescribing JS Shaw, RL Wilmot, ES Kilpatrick Diabetic Medicine 24 (10), 1160-1163, 2007 | 152 | 2007 |
| Glycated haemoglobin in the year 2000 ES Kilpatrick Journal of clinical pathology 53 (5), 335-339, 2000 | 151 | 2000 |
| Paradoxical changes in cystatin C and serum creatinine in patients with hypo-and hyperthyroidism V Jayagopal, BG Keevil, SL Atkin, PE Jennings, ES Kilpatrick Clinical chemistry 49 (4), 680-681, 2003 | 148 | 2003 |
Stephen AtkinRCSI BahrainVerified email at rcsi.com
